CFB/C2 gene polymorphisms and risk of age-related macular degeneration: A systematic review and meta-analysis

Current Eye Research

Volumn 37, Issue 4, 2012, Pages 259-271

  Sun, Chuan ^a   Zhao, Min ^a   Li, Xiaoxin ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Age related macular degeneration; CFB C2 gene; Meta analysis; Polymorphisms; Systematic review

Indexed keywords

ALLELE; CFB/C2 GENE; CONFIDENCE INTERVAL; DATA EXTRACTION; DISEASE ASSOCIATION; EMBASE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SCREENING; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

COMPLEMENT C2; COMPLEMENT FACTOR B; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MACULAR DEGENERATION; POLYMORPHISM, GENETIC;

EID: 84859024248     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.635401     Document Type: Review

References (57)

1. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564-572.
2. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137:486-495. (Pubitemid 38328641)
3. Rama DJ, William FM, Joan WM. Age-related macular degeneration. N Engl J Med. 2008;358:2606-2617.
4. Montes T, Tortajada A, Morgan BP, Rodríguez de Córdoba S, Harris CL. Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B. Proc Natl Acad Sci USA. 2009;106:4366-4371.
5. Scholl HP, Fleckenstein M, Charbel Issa P, Keilhauer C, Holz FG, Weber BH. An update on the genetics of age-related macular degeneration. Mol Vis. 2007;13:196-205. (Pubitemid 46232110)
6. Chong EW, Kreis AJ, Wong TY, Simpson JA, Guymer RH. Alcohol consumption and the risk of age-related macular degeneration: a systematic review and meta-analysis. Am J Ophthalmol. 2008;145:707-715.
7. Chaine G, Hullo A, Sahel J et al. Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group. Br J Ophthalmol. 1998;82:996-1002. (Pubitemid 28451268)
8. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration A case-control study in the age-related eye disease study: Age-related eye disease study report number 3. Ophthalmol. 2000;107:2224-2232.
9. Miyazaki M, Nakamura H, Kubo M et al. Risk factors for age related maculopathy in a Japanese population: the Hisayama study. Br J Ophthalmol. 2003;87:469-472. (Pubitemid 36399038)
10. Krishnaiah S, Das T, Nirmalan PK et al. Risk factors for agerelated macular degeneration: findings from the Andhra Pradesh eye disease study in South India. Invest Ophthalmol Vis Sci. 2005;46:4442-4449. (Pubitemid 44264537)
11. Tomany SC, Wang JJ, Van Leeuwen R et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004;111: 1280-1287. (Pubitemid 38844822)
12. Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS. Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol. 2010;128:349-358.
13. Rodrigues EB. Inflammation in dry age-related macular degeneration. Ophthalmologica. 2007;221:143-152. (Pubitemid 46631914)
14. Anderson DH, Radeke MJ, Gallo NB et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2010;29:95-112.
15. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-431.
16. Postel EA, Agarwal A, Caldwell J et al. Complement factor H increases risk for atrophic age-related macular degeneration. Ophthalmology. 2006;113:1504-1507. (Pubitemid 44292298)
17. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and agerelated macular degeneration. Science. 2005;308:421-424. (Pubitemid 40530082)
18. Despriet DD, Klaver CC, Witteman JC et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006;296:301-309. (Pubitemid 44079314)
19. Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421. (Pubitemid 40530081)
20. Doney AS, Leese GP, Olson J, Morris AD, Palmer CN. The Y402H variant of complement factor H is associated with agerelated macular degeneration but not with diabetic retinal disease in the Go-DARTS study. Diabet Med. 2009;26:460-465.
21. Spencer KL, Olson LM, Anderson BM et al. C3 R102G polymorphism increases risk of age-related macular degeneration. Hum Mol Genet. 2008;17:1821-1824. (Pubitemid 351791509)
22. McKay GJ, Dasari S, Patterson CC, Chakravarthy U, Silvestri G. Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. Mol Vis. 2010;16:194-199.
23. Despriet DD, van Duijn CM, Oostra BA et al. Complement component C3 and risk of age-related macular degeneration. Ophthalmology. 2009;116:474-480.e2.
24. Richardson AJ, Islam FM, Guymer RH, Baird PN. Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci. 2009;50:540-543.
25. Chen Y, Zeng J, Zhao C et al. Assessing susceptibility to agerelated macular degeneration with genetic markers and environmental factors. Arch Ophthalmol. 2011;129:344-351.
26. Pei XT, Li XX, Bao YZ et al. Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a chinese population. Curr Eye Res. 2009;34:615-622.
27. Liu X, Zhao P, Tang S et al. Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population. Retina (Philadelphia, Pa). 2010;30:1177-1184.
28. Jakobsdottir J, Conley YP, Weeks DE, Ferrell RE, Gorin MB. C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. PLoS ONE. 2008;3:e2199.
29. Edwards AO, Fridley BL, James KM et al. Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study. PLoS ONE. 2008;3:e3813.
30. McKay GJ, Silvestri G, Patterson CC, Hogg RE, Chakravarthy U, Hughes AE. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009;50:533-539.
31. Chu J, Zhou CC, Lu N, Zhang X, Dong FT. Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin Med J. 2008;121:2525-2533.
32. Ryu E, Fridley BL, Tosakulwong N, Bailey KR, Edwards AO. Genome-wide association analyses of genetic, phenotypic, and environmental risks in the age-related eye disease study. Mol Vis. 2010;16:2811-2821.
33. Kaur I, Katta S, Reddy RK et al. The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2010;51:59-63.
34. Bergeron-Sawitzke J, Gold B, Olsh A et al. Multilocus analysis of age-related macular degeneration. Eur J Hum Genet. 2009;17:1190-1199.
35. Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML. Polymorphisms in C2, CFB and C3 are associated withprogression to advaned age related macular degeneration associated with visual loss. J Med Genet. 2009;46:300-307.
36. Baatz H, Poupel L, Coudert M, Sennlaub F, Combadiere C. [Polymorphisms of complement factor genes and age-related macular degeneration in a German population]. Klin Monbl Augenheilkd. 2009;226:654-658.
37. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50:2044-2053.
38. Spencer KL, Hauser MA, Olson LM et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet. 2007;16:1986-1992. (Pubitemid 47354881)
39. Reynolds R, Rosner B, Seddon JM. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology. 2010;117:1989-1995.
40. Scholl HP, Charbel Issa P, Walier M et al. Systemic complement activation in age-related macular degeneration. PLoS ONE. 2008;3:e2593.
41. Gold B, Merriam JE, Allikmets R et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with agerelated macular degeneration. Nat Genet. 2006;38:458-462.
42. Farwick A, Dasch B, Weber BH, Pauleikhoff D, Stoll M, Hense HW. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study. Eye (Lond). 2009;23:2238-2244.
43. Ioannidis JP, Patsopoulos NA, Evangelou E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS ONE. 2007;2:e841.
44. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. (Pubitemid 37088507)
45. Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol. 1995;48:45-57; discussion 59.
46. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248-254.
47. Petersa JL, Suttona AJ, Jones DR et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61:991-996.
48. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323:224-228.
49. Schaid DJ, Batzler AJ, Jenkins GD, Hildebrandt MA. Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. Am J Hum Genet. 2006;79:1071-1080. (Pubitemid 44853478)
50. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005;76:887-893. (Pubitemid 40563110)
51. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56:297-303. (Pubitemid 36593307)
52. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634. (Pubitemid 27387172)
53. Rücker G, Carpenter JR, Schwarzer G. Detecting and adjusting for small-study effects in meta-analysis. Biom J. 2011;53:351-368.
54. Moreno SG, Sutton AJ, Turner EH et al. Novel methods to deal with publication biases: secondary analysis of antidepressant trials in the FDA trial registry database and related journal publications. BMJ. 2009;339:b2981.
55. Charbel Issa P, Chong NV, Scholl HP. The significance of the complement system for the pathogenesis of age-related macular degeneration-current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol. 2011;249:163-174.
56. Lokki ML, Koskimies SA. Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes. Immunogenetics. 1991;34:242-246.
57. Mei Chen, Muckersie E, Robertson M, Forrester JV., Heping Xu. Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp Eye Res. 2008;87:543-550.